# Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT

> **NCT01212354** · PHASE3 · UNKNOWN · sponsor: **Technical University of Munich** · enrollment: 270 (estimated)

## Conditions studied

- Locally Advanced Head and Neck Cancer

## Interventions

- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT01212354
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2025-01
- **Final completion:** 2025-09
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2016-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01212354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01212354, "Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01212354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*